ATNFR1genotype with a protective role in familial rheumatoid arthritis
Open Access
- 5 February 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (2) , 413-419
- https://doi.org/10.1002/art.20055
Abstract
Objective Results of genome scans in rheumatoid arthritis (RA) have suggested that the tumor necrosis factor receptor I (TNFRI) and TNFRII loci (TNFR1 and TNFR2) are susceptibility loci. A TNFR2 polymorphism was found to be associated with familial RA. TNFR1 is mutated in TNFR‐associated periodic syndrome (TRAPS). We undertook this study to test the TNFR1 exonic polymorphism closest to the TRAPS mutations site (+36 A/G) for association with RA. Methods DNA samples were available from two groups of the French Caucasian population: 1) 100 families with 1 RA patient and both parents and 2) 86 RA index patients from families with at least 2 siblings with RA (affected sibpairs [ASPs]). The +36 A/G polymorphism of TNFR1 was genotyped by polymerase chain reaction–restriction fragment length polymorphism. The analysis was performed using the transmission disequilibrium test, the genotype relative risk, and a linkage‐based test previously described. Results A negative association between RA and the +36 A/A genotype, suggested in the first sample (P = 0.084), was demonstrated in the second (ASP RA) sample (odds ratio [OR] 0.465; P = 0.012) and confirmed by the linkage‐based test (OR 0.17; P = 0.008). The protective genotype, present in 41% of controls, was less frequent in RA patients: 33% in the first sample, 24% in the ASP RA sample, and 11% in the linkage‐derived subgroup. Distribution of both TNFR2 196 R/R and TNFR1 +36 A/A genotypes in the ASP RA sample showed that both suspected genotypes were exclusive. Conclusion We found evidence for an association between RA and a TNFR1 protective genotype, restricted to familial RA. Distribution of the TNFR2 196 R/R and TNFR1 +36 A/A genotypes in familial RA could suggest an interaction between TNFR1 and TNFR2 in the genetic susceptibility for RA.Keywords
Funding Information
- Fondation pour la Recherche Médicale
- Association Française des Polyarthritiques
- Association de Recherche pour la Polyarthrite
- Société Française de Rhûmatologie
- Association Rhumatisme et Travail, Genopole
- Conseil Régional Ile de France
- Ministère de la Recherche et de l'Enseignement Supérieur
- Schering-Plough
- Pharmacia
- Pfizer
- Wyeth
- Académie Nationale de Médecine
This publication has 35 references indexed in Scilit:
- Single‐nucleotide polymorphisms in tumor necrosis factor receptor genes: Definition of novel haplotypes and racial/ethnic differencesArthritis & Rheumatism, 2002
- A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal‐dominant recurrent feverArthritis & Rheumatism, 2002
- Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid CommunicationKidney International, 2001
- A Genomewide Screen in Multiplex Rheumatoid Arthritis Families Suggests Genetic Overlap with Other Autoimmune DiseasesAmerican Journal of Human Genetics, 2001
- Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical updateAnnals of the Rheumatic Diseases, 2000
- Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen‐induced arthritisArthritis & Rheumatism, 2000
- An MspA1 I polymorphism in exon 1 of the human TNF receptor type I (p55) geneEuropean Journal of Immunogenetics, 1998
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease.Annals of the Rheumatic Diseases, 1983